, a bio/informatics shared resource is still "open for business" - Visit the CDS website


  1. Functional characterization of genetic variants in the apical sodium-dependent bile acid transporter (ASBT; SLC10A2). Ho RH, Leake BF, Urquhart BL, Gregor JC, Dawson PA, Kim RB (2011) J Gastroenterol Hepatol 26(12): 1740-8
    › Primary publication · 21649730 (PubMed) · PMC3170668 (PubMed Central)
  2. Dapsone-induced methemoglobinemia: a dose-related occurrence? Esbenshade AJ, Ho RH, Shintani A, Zhao Z, Smith LA, Friedman DL (2011) Cancer 117(15): 3485-92
    › Citation · 21246536 (PubMed) · PMC3138875 (PubMed Central)
  3. A unique clinical presentation of X-linked lymphoproliferative syndrome with a novel mutation in SH2D1A and review of the literature. Eckrich MJ, Yang E, Domm J, Ho R, Calder C, Manes B, Bleesing J, Frangoul H (2011) J Pediatr Hematol Oncol 33(1): e39-42
    › Citation · 20975587 (PubMed)
  4. Polymorphic variants in the human bile salt export pump (BSEP; ABCB11): functional characterization and interindividual variability. Ho RH, Leake BF, Kilkenny DM, Meyer Zu Schwabedissen HE, Glaeser H, Kroetz DL, Kim RB (2010) Pharmacogenet Genomics 20(1): 45-57
    › Primary publication · 20010382 (PubMed) · PMC2883163 (PubMed Central)
  5. Preengraftment syndrome after unrelated cord blood transplant is a strong predictor of acute and chronic graft-versus-host disease. Frangoul H, Wang L, Harrell FE, Ho R, Domm J (2009) Biol Blood Marrow Transplant 15(11): 1485-8
    › Citation · 19822310 (PubMed)
  6. Initial vancomycin dosing in pediatric oncology and stem cell transplant patients. Piro CC, Crossno CL, Collier A, Ho R, Koyama T, Frangoul H (2009) J Pediatr Hematol Oncol 31(1): 3-7
    › Citation · 19125078 (PubMed)
  7. Autologous stem cell transplant in a patient with Down syndrome and relapsed Hodgkin lymphoma. Eckrich MJ, Domm J, Ho R, Whitlock JA, Frangoul H (2009) Pediatr Blood Cancer 53(7): 1327-8
    › Citation · 19760777 (PubMed)
  8. Use of human androgen receptor gene analysis to aid the diagnosis of JMML in female noonan syndrome patients. Lavin VA, Hamid R, Patterson J, Alford C, Ho R, Yang E (2008) Pediatr Blood Cancer 51(2): 298-302
    › Citation · 18454468 (PubMed)
  9. Interplay between the nuclear receptor pregnane X receptor and the uptake transporter organic anion transporter polypeptide 1A2 selectively enhances estrogen effects in breast cancer. Meyer zu Schwabedissen HE, Tirona RG, Yip CS, Ho RH, Kim RB (2008) Cancer Res 68(22): 9338-47
    › Primary publication · 19010908 (PubMed) · PMC2597047 (PubMed Central)
  10. Breast cancer resistance protein (ABCG2) and drug disposition: intestinal expression, polymorphisms and sulfasalazine as an in vivo probe. Urquhart BL, Ware JA, Tirona RG, Ho RH, Leake BF, Schwarz UI, Zaher H, Palandra J, Gregor JC, Dresser GK, Kim RB (2008) Pharmacogenet Genomics 18(5): 439-48
    › Primary publication · 18408567 (PubMed) · PMC4043148 (PubMed Central)